Security Snapshot

Starling Oncology, Inc. - Common Stock, par value $0.0001 per share (STLN) Institutional Ownership

CUSIP: 68236X100

13F Institutional Holders and Ownership History from Q3 2021 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

88

Shares (Excl. Options)

30.93MFull value: 30,928,455 · shares · 30 Sep 2026

Price

$6.32

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+2,357,512
Value change
+$16,806,209
Number of holders
88
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
101,268,340
SEC-reported price per share
$6.59
Insider filing price
$6.59
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • STLN - Starling Oncology, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 68236X100.
  • 88 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 119 to 88 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $217.59MFull value: $217,594,640 · USD · 30 Jun 2026
    to
    $195.67MFull value: $195,674,982 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 88 institutions filings for Q3 2026.

Open SEC evidence

Security key

68236X100

13F reference period

Q3 2026

13F holders

88

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
STLN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Chernett Jorey 10% $27,110,730 10,115,944 Chernett Jorey 13 Mar 2026
M33 Growth I L.P. 4.9% $15,408,180 5,002,656 M33 Growth I L.P. 14 May 2026
SARIN RAVI YANG 4.7% $11,959,434 4,109,771 Ravi Sarin 26 Mar 2025
As of 30 Sep 2026, 88 institutional investors reported holding
30.93MFull value: 30,928,455 · shares · 30 Sep 2026
shares of Starling Oncology, Inc. - Common Stock, par value $0.0001 per share (STLN). This represents 31% of the company’s total
101.27MFull value: 101,268,340 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
25%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 3.4% 3,471,514 0% $21,939,968
DEERFIELD MANAGEMENT COMPANY, L.P. 3.3% 3,360,052 0.33% $21,235,529
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 2.5% 2,493,109 10% $15,756,449
GEODE CAPITAL MANAGEMENT, LLC 2.1% 2,111,736 0% $13,349,695
STATE STREET CORP 2% 1,978,307 0% $12,502,900
WEXFORD CAPITAL LP 1.7% 1,711,323 1.5% $10,815,561
GOLDMAN SACHS GROUP INC 1.2% 1,203,272 0% $7,604,679
RENAISSANCE TECHNOLOGIES LLC 1.2% 1,178,277 0.01% $7,446,711
VANGUARD PORTFOLIO MANAGEMENT LLC 1% 1,052,364 0% $6,650,940
TWO SIGMA INVESTMENTS, LP 0.85% 858,198 0% $5,423,811
BRC Group Holdings, Inc. 0.71% 722,381 2.5% $4,565,448
Informed Momentum Co LLC 0.71% 718,398 0.47% $4,540,275
VANGUARD FIDUCIARY TRUST CO 0.59% 600,868 0% $3,797,486
MARSHALL WACE, LLP 0.53% 534,854 0% $3,380,276
Manatuck Hill Partners, LLC 0.52% 525,000 1.1% $3,318,000
Point72 Asset Management, L.P. 0.41% 411,629 0% $2,601,495
FORMULA GROWTH LTD 0.36% 368,400 0.9% $2,328,288
Panoramic Capital, LLC 0.32% 327,835 0.83% $2,071,917
BANK OF AMERICA CORP /DE/ 0.29% 296,052 0% $1,871,048
Invesco Ltd. 0.26% 267,953 0% $1,693,463
Mount Lucas Management LP 0.2% 200,000 0.52% $1,264,000
STEMPOINT CAPITAL LP 0.15% 156,663 0.18% $990,110
Qube Research & Technologies Ltd 0.15% 155,933 0% $985,497
Creative Planning 0.14% 141,507 0% $894,323
KINGSWOOD WEALTH ADVISORS, LLC 0.13% 136,401 0.03% $862,054

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
21
Headline period
Q3 2026
Rows shown
1-21 of 21
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 30,928,455 $195,674,982 +$16,806,209 $6.32 88
2026 Q2 40,091,307 $217,594,640 +$22,260,959 $5.43 119
2026 Q1 38,763,593 $118,924,902 -$589,812 $3.07 115
2025 Q4 38,505,676 $137,199,596 +$13,731,282 $3.56 116
2025 Q3 34,670,910 $120,993,806 +$10,399,257 $3.49 107
2025 Q2 31,474,503 $64,523,702 +$31,211,552 $2.05 78
2025 Q1 16,901,932 $19,267,414 +$2,727,938 $1.14 42
2024 Q4 14,712,600 $4,608,917 -$2,191,797 $0.31 30
2024 Q3 20,589,694 $6,982,762 +$385,704 $0.33 34
2024 Q2 18,701,866 $8,832,828 -$155,334 $0.46 38
2024 Q1 17,222,037 $27,535,675 -$2,492,260 $1.58 44
2023 Q4 18,436,129 $37,608,749 +$6,554,810 $2.04 44
2023 Q3 15,107,160 $21,169,015 +$1,157,191 $1.40 36
2023 Q2 13,916,345 $7,656,692 -$4,490,020 $0.55 37
2023 Q1 21,905,923 $14,849,314 -$1,309,674 $0.68 37
2022 Q4 23,473,725 $38,730,078 -$1,269,944 $1.65 37
2022 Q3 23,327,364 $108,006,612 +$6,672,135 $4.63 39
2022 Q2 21,874,386 $110,684,000 +$2,844,383 $5.06 33
2022 Q1 17,791,143 $126,852,000 -$752,294 $7.13 27
2021 Q4 21,118,138 $199,883,000 +$185,679,000 $9.75 21
2021 Q3 252,439 $2,504,000 +$2,504,000 $9.92 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .